The Effect of NELL1 and Bone Morphogenetic Protein-2 on Calvarial Bone Regeneration

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 2, 2010, Pages 300-308

  Aghaloo, Tara ^a   Cowan, Catherine M ^b   Zhang, Xinli ^b   Freymiller, Earl ^c   Soo, Chia ^c   Wu, Benjamin ^c   Ting, Kang ^a   Zhang, Zhiyuan ^d  

^a School of Dentistry   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; NEL LIKE MOLECULE 1 PROTEIN; POLYGLACTIN; PROTEIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; BONE REGENERATION; CALVARIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENTIATION; HEALING; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; IN VIVO STUDY; LOW DRUG DOSE; MALE; MICRO-COMPUTED TOMOGRAPHY; MONOTHERAPY; NONHUMAN; OSSIFICATION; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG SYNERGISM; HUMANS; LACTIC ACID; MALE; NERVE TISSUE PROTEINS; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SKULL; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 73949149208     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.03.066     Document Type: Article

References (66)

1. Bardach J., and Morris H. Multidisciplinary Management of Cleft Lip and Palate (1990), Saunders, Philadelphia
2. Cohen M., and MacLean R. Craniosynostosis: Diagnosis, Evaluation, and Management (2000), Oxford, New York
3. Cohen Jr. M.M. Craniofacial disorders caused by mutations in homeobox genes MSX1 and MSX2. J Craniofac Genet Dev Biol 20 (2000) 19
4. Canady J.W., Zeitler D.P., Thompson S.A., et al. Suitability of the iliac crest as a site for harvest of autogenous bone grafts. Cleft Palate Craniofac J 30 (1993) 579
5. Franceschi R.T. Biological approaches to bone regeneration by gene therapy. J Dent Res 84 (2005) 1093
6. Frodel Jr. J.L., Marentette L.J., Quatela V.C., et al. Calvarial bone graft harvest. Techniques, considerations, and morbidity. Arch Otolaryngol Head Neck Surg 119 (1993) 17
7. Frodel J.L., and Marentette L.J. The coronal approach. Anatomic and technical considerations and morbidity. Arch Otolaryngol Head Neck Surg 119 (1993) 201
8. Enneking W.F., and Mindell E.R. Observations on massive retrieved human allografts. J Bone Joint Surg Am 73 (1991) 1123
9. Friedlaender G.E. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res (1983) 58
10. Garofalo G.S. Autogenous, allogenetic and xenogenetic grafts for maxillary sinus elevation: Literature review, current status and prospects. Minerva Stomatol 56 (2007) 373
11. Urist M.R. Bone: Formation by autoinduction. Science 150 (1965) 893
12. Aghaloo T., Cowan C.M., Chou Y.F., et al. Nell-1-induced bone regeneration in calvarial defects. Am J Pathol 169 (2006) 903
13. Chung Y.I., Ahn K.M., Jeon S.H., et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 121 (2007) 91
14. Cowan C.M., Aghaloo T., Chou Y.F., et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 13 (2007) 501
15. Kamakura S., Nakajo S., Suzuki O., et al. New scaffold for recombinant human bone morphogenetic protein-2. J Biomed Mater Res A 71 (2004) 299
16. Boyne P.J. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 83 suppl 1 (2001) S146
17. Dickinson B.P., Ashley R.K., Wasson K.L., et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 121 (2008) 209
18. Herford A.S., and Boyne P.J. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66 (2008) 616
19. Bonadio J., Smiley E., Patil P., et al. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 5 (1999) 753
20. Garrison K.R., Donell S., Ryder J., et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 11 (2007) 1
21. Minamide A., Yoshida M., Kawakami M., et al. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30 (2005) 1134
22. Tang T.T., Xu X.L., Dai K.R., et al. Ectopic bone formation of human bone morphogenetic protein-2 gene transfected goat bone marrow-derived mesenchymal stem cells in nude mice. Chin J Traumatol 8 (2005) 3
23. Valentin-Opran A., Wozney J., Csimma C., et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res (2002) 110
24. van den Bergh J.P., ten Bruggenkate C.M., Groeneveld H.H., et al. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol 27 (2000) 627
25. Zhang X., Kuroda S., Carpenter D., et al. Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 110 (2002) 861
26. Cowan C.M., Jiang X., Hsu T., et al. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J Bone Miner Res 22 (2007) 918
27. Cowan C., Shi Y., Aalami O., et al. Adipose-derived adult stromal cells heal critical-sized mouse calvarial defects. Nat Biotechnol 22 (2004) 560
28. Kuroda S., Oyasu M., Kawakami M., et al. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res Commun 265 (1999) 79
29. Bosch C., Melsen B., and Vargervik K. Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg 9 (1998) 310
30. Berger F., Lee Y.P., Loening A.M., et al. Whole-body skeletal imaging in mice utilizing microPET: Optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging 29 (2002) 1225
31. Borah B., Dufresne T.E., Cockman M.D., et al. Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res 15 (2000) 1786
32. Aghaloo T., Jiang X., Soo C., et al. A study of the role of Nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther 15 (2007) 1872
33. Jiang Y., Zhao J., White D.L., et al. Micro CT and Micro MR imaging of 3D architecture of animal skeleton. J Musculoskelet Neuronal Interact 1 (2000) 45
34. Link T.M., and Bauer J.S. Imaging of trabecular bone structure. Semin Musculoskelet Radiol 6 (2002) 253
35. Thomsen J.S., Laib A., Koller B., et al. Stereological measures of trabecular bone structure: Comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies. J Microsc 218 (2005) 171
36. Boyne P.J., Lilly L.C., Marx R.E., et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63 (2005) 1693
37. Fiorellini J.P., Howell T.H., Cochran D., et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 76 (2005) 605
38. Jones A.L., Bucholz R.W., Bosse M.J., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88 (2006) 1431
39. Nevins M., Camelo M., Nevins M.L., et al. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 74 (2003) 1282
40. O'Shaughnessy B.A., Kuklo T.R., and Ondra S.L. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2. Spine 33 (2008) E132
41. Chen D., Harris M.A., Rossini G., et al. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60 (1997) 283
42. Siddappa R., Martens A., Doorn J., et al. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A 105 (2008) 7281
43. Govender S., Csimma C., Genant H.K., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84 (2002) 2123
44. Martin Jr. G.J., Boden S.D., Marone M.A., et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12 (1999) 179
45. Ting K., Vastardis H., Mulliken J.B., et al. Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res 14 (1999) 80
46. Zhang X., Carpenter D., Bokui N., et al. Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 18 (2003) 2126
47. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577
48. Lee K.S., Hong S.H., and Bae S.C. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21 (2002) 7156
49. Nishimura R., Hata K., Harris S.E., et al. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31 (2002) 303
50. Cowan C.M., Cheng S., Ting K., et al. Nell-1 induced bone formation within the distracted intermaxillary suture. Bone 38 (2006) 48
51. Truong T., Zhang X., Pathmanathan D., et al. Craniosynostosis-associated gene nell-1 is regulated by runx2. J Bone Miner Res 22 (2007) 7
52. Zhang X., Cowan C.M., Jiang X., et al. Nell-1 induces acrania-like cranioskeletal deformities during mouse embryonic development. Lab Invest 86 (2006) 633
53. Frazza E.J., and Schmitt E.E. A new absorbable suture. J Biomed Mater Res 5 (1971) 43
54. Jung R.E., Weber F.E., Thoma D.S., et al. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalcium phosphate. Clin Oral Implants Res 19 (2008) 188
55. Kempen D.H., Lu L., Hefferan T.E., et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29 (2008) 3245
56. Takahashi Y., Yamamoto M., Yamada K., et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 13 (2007) 293
57. Kha H.T., Basseri B., Shouhed D., et al. Oxysterols regulate differentiation of mesenchymal stem cells: Pro-bone and anti-fat. J Bone Miner Res 19 (2004) 830
58. Yeh L.C., Zavala M.C., and Lee J.C. C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation. J Cell Biochem 97 (2006) 494
59. Yeh L.C., Zavala M.C., and Lee J.C. Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. J Cell Physiol 190 (2002) 322
60. Yeh L.C., Tsai A.D., Zavala M.C., et al. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells. J Cell Physiol 201 (2004) 401
61. Ghosh-Choudhury N., Mandal C.C., and Choudhury G.G. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 282 (2007) 4983
62. Yamashita M., Otsuka F., Mukai T., et al. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol 196 (2008) 601
63. Yazawa H., Zimmermann B., Asami Y., et al. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. J Periodontol 76 (2005) 295
64. Peng H., Wright V., Usas A., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110 (2002) 751
65. Chan G.K., Miao D., Deckelbaum R., et al. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology 144 (2003) 5511
66. Peng H., Usas A., Olshanski A., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20 (2005) 2017